A randomized clinical trial comparing long-term clopidogrel versus aspirin monotherapy beyond dual antiplatelet therapy after drug-eluting coronary stent implantation: Design and rationale of the HOST-EXAM trial
Conclusions The HOST-EXAM will be the first large-scale randomized controlled study to directly compare the efficacy and safety of long-term antiplatelet monotherapy beyond DAPT after DES implantation. This study will provide clinical evidence to establish optimal regimen for long-term antiplatelet therapy after DES implantation.
Source: American Heart Journal - Category: Cardiology Source Type: research
More News: Angioplasty | Aspirin | Bleeding | Cardiology | Clinical Trials | Clopidogrel | Coronary Angioplasty | Heart | Heart Attack | Percutaneous Coronary Intervention | Plavix | Stroke | Study | Thrombosis